• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Answer to the "Glucocorticoid therapy in patients with COVID-19 and concurrent heart failure" correspondence.

作者信息

Salinas-Botrán A, Pérez-Belmonte L M, Méndez-Bailón M

机构信息

Servicio de Medicina Interna, Hospital Clínico San Carlos, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria delHospital ClínicoSan Carlos (IdISSC),Madrid, Spain.

Servicio de Medicina Interna, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Universidad de Málaga (UMA), Málaga, Spain.

出版信息

Rev Clin Esp (Barc). 2022 May;222(5):310-311. doi: 10.1016/j.rceng.2021.11.001. Epub 2022 Jan 24.

DOI:10.1016/j.rceng.2021.11.001
PMID:35101382
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8784579/
Abstract
摘要

相似文献

1
Answer to the "Glucocorticoid therapy in patients with COVID-19 and concurrent heart failure" correspondence.对“COVID-19合并心力衰竭患者的糖皮质激素治疗”信件的回复。
Rev Clin Esp (Barc). 2022 May;222(5):310-311. doi: 10.1016/j.rceng.2021.11.001. Epub 2022 Jan 24.
2
Glucocorticoid therapy in patients with COVID-19 and concurrent heart failure.新冠病毒病合并心力衰竭患者的糖皮质激素治疗
Rev Clin Esp (Barc). 2022 May;222(5):309-310. doi: 10.1016/j.rceng.2021.11.002. Epub 2022 Jan 31.
3
Corticosteroid therapy in patients with heart failure hospitalized for COVID-19: a multicenter retrospective study.因COVID-19住院的心力衰竭患者的皮质类固醇治疗：一项多中心回顾性研究。
Intern Emerg Med. 2021 Nov;16(8):2301-2305. doi: 10.1007/s11739-021-02843-4. Epub 2021 Oct 12.
4
Heart failure and COVID-19: synergism of two inflammatory conditions?心力衰竭与 COVID-19：两种炎症状态的协同作用？
Br J Community Nurs. 2021 Jan 2;26(1):18-25. doi: 10.12968/bjcn.2021.26.1.18.
5
[Answer to the "Glucocorticoid therapy in patients with COVID-19 and concurrent heart failure" correspondence].[对“COVID-19合并心力衰竭患者的糖皮质激素治疗”信件的回复]
Rev Clin Esp. 2022 May;222(5):310-311. doi: 10.1016/j.rce.2021.11.001. Epub 2021 Nov 20.
6
Cardiac outcome prevention effectiveness of glucocorticoids in acute decompensated heart failure: COPE-ADHF study.糖皮质激素对急性失代偿性心力衰竭的心脏结局预防效果：COPE-ADHF研究
J Cardiovasc Pharmacol. 2014 Apr;63(4):333-8. doi: 10.1097/FJC.0000000000000048.
7
Acute Biventricular Heart Failure After COVID-19 Infection in an Orthotropic Heart Transplant Patient: A Case Report.COVID-19 感染后心脏移植患者的双心室急性心力衰竭：病例报告。
Transplant Proc. 2021 May;53(4):1224-1226. doi: 10.1016/j.transproceed.2021.03.013. Epub 2021 Mar 19.
8
Maternal pulmonary edema resulting from betamimetic and glucocorticoid therapy.
Obstet Gynecol. 1980 Jul;56(1):56-9.
9
Managing Covid-19 in patients with heart failure: current status and future prospects.管理心力衰竭合并新冠病毒感染（Covid-19）患者：现状与未来前景。
Expert Rev Cardiovasc Ther. 2022 Oct;20(10):807-828. doi: 10.1080/14779072.2022.2132230. Epub 2022 Oct 12.
10
Glucocorticoids Reverse Diluted Hyponatremia Through Inhibiting Arginine Vasopressin Pathway in Heart Failure Rats.糖皮质激素通过抑制心力衰竭大鼠的精氨酸加压素途径来逆转稀释性低钠血症。
J Am Heart Assoc. 2020 May 18;9(10):e014950. doi: 10.1161/JAHA.119.014950. Epub 2020 May 9.

引用本文的文献

1
Differences in clinical features and mortality in very old unvaccinated patients (≥ 80 years) hospitalized with COVID-19 during the first and successive waves from the multicenter SEMI-COVID-19 Registry (Spain).在多中心 SEMI-COVID-19 注册中心（西班牙），首次和后续波次期间，≥ 80 岁的未接种疫苗的 COVID-19 住院老年患者（非常老）的临床特征和死亡率存在差异。
BMC Geriatr. 2022 Jun 30;22(1):546. doi: 10.1186/s12877-022-03191-4.

本文引用的文献

1
[Glucocorticoid therapy in patients with COVID-19 and concurrent heart failure].[新型冠状病毒肺炎合并心力衰竭患者的糖皮质激素治疗]
Rev Clin Esp. 2022 May;222(5):309-310. doi: 10.1016/j.rce.2021.11.002. Epub 2021 Nov 20.
2
Adverse outcomes in patients with heart failure admitted for COVID‑19 in association with the use of renin-angiotensin‑aldosterone system inhibitors.
Pol Arch Intern Med. 2022 Jan 28;132(1). doi: 10.20452/pamw.16126. Epub 2021 Oct 22.
3
Corticosteroid therapy in patients with heart failure hospitalized for COVID-19: a multicenter retrospective study.因COVID-19住院的心力衰竭患者的皮质类固醇治疗：一项多中心回顾性研究。
Intern Emerg Med. 2021 Nov;16(8):2301-2305. doi: 10.1007/s11739-021-02843-4. Epub 2021 Oct 12.
4
[Clinical characteristics and risk factors for mortality upon admission in patients with heart failure hospitalized due to COVID-19 in Spain].[西班牙因COVID-19住院的心力衰竭患者入院时的临床特征及死亡风险因素]
Rev Clin Esp. 2022 May;222(5):255-265. doi: 10.1016/j.rce.2021.06.004. Epub 2021 Jul 17.
5
[Clinical characteristics of patients hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 Registry].[西班牙新冠肺炎住院患者的临床特征：SEMI-COVID-19登记研究结果]
Rev Clin Esp. 2020 Nov;220(8):480-494. doi: 10.1016/j.rce.2020.07.003. Epub 2020 Jul 19.
6
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.